Strategic investment backs UpDoc's clinical AI platform, deploying patient-facing AI agents to transform chronic disease care at scale

战略投资支持UpDoc临床AI平台，部署面向患者的AI智能体，推动慢性病护理规模化转型。

ARLINGTON, Va.

弗吉尼亚州阿灵顿

,

，

June 2, 2026

2026年6月2日

/PRNewswire/ -- Today, the American Diabetes Association

/PRNewswire/ —— 今日，美国糖尿病协会

®

注册商标

(ADA) announced a strategic investment in

（ADA）宣布对……进行战略投资

UpDoc

UpDoc

, an enterprise-ready clinical artificial intelligence (AI) company developing physician-grade agentic AI. The investment from the

，一家具备企业级应用能力的临床人工智能（AI）公司，致力于研发医师级智能体AI。此次来自

ADA's Innovation Fund

ADA创新基金

validates UpDoc's evidence-based approach to chronic disease management and will accelerate the company's mission to deliver clinical-grade, agentic AI-powered interventions to millions of people living with diabetes and related conditions.

验证了UpDoc在慢性病管理领域的循证方法，并将加速公司实现其使命：为数百万糖尿病及相关疾病患者提供临床级、智能体AI驱动的干预措施。

The ADA Innovation Fund was established to identify and accelerate transformative diabetes and cardiometabolic innovations that have the potential to fundamentally alter outcomes for people living with diabetes, obesity, or both. The fund's investment in UpDoc reflects the conviction that clinical AI, when deployed responsibly and at scale, can meaningfully close the gap between the care people need and the care they receive..

ADA创新基金的设立旨在发掘并加速推进具有变革性的糖尿病与心脏代谢创新成果，这些成果有望从根本上改善糖尿病、肥胖症或二者共病患者的临床结局。该基金对UpDoc的投资体现了这样一种信念：临床人工智能在负责任地进行大规模应用时，能够实质性弥合患者所需照护与实际获得照护之间的差距。

'The American Diabetes Association exists to prevent and cure diabetes and to improve the lives of people affected by diabetes. This mission demands that we invest in innovative solutions that will bend the curve on this disease,' said Charles 'Chuck' Henderson, the ADA's chief executive officer. 'UpDoc's approach is a category-defining leap in how we think about care coordination, patient engagement, and chronic disease management.

“美国糖尿病协会的宗旨是预防和治疗糖尿病，并改善受糖尿病影响人群的生活。这一使命要求我们投资于创新解决方案，以扭转该疾病的发展趋势，”美国糖尿病协会首席执行官查尔斯·“查克”·亨德森表示，“UpDoc的方案在我们对护理协调、患者参与和慢性病管理的思考方式上，实现了一次具有开创意义的跨越。”

We are proud to support a company with the scientific rigor, clinical credibility, and entrepreneurial ambition to make this vision a reality for the people who need it most.'.

我们为能够支持这样一家公司而感到自豪：它具备科学严谨性、临床公信力与创业雄心，致力于为最需要的人群将这一愿景变为现实。

Over 40 million Americans are living with diabetes, and diagnosed diabetes accounts for 1 of every 4 healthcare dollars spent in the United States. In addition, millions more are living with other chronic diseases, some of which they developed as a complication of diabetes. Yet the healthcare system's ability to reach people continuously and proactively, outside of scheduled appointments, remains severely constrained by clinician shortages, administrative burden, and the limits of traditional care delivery models.

超过4000万美国人患有糖尿病，在美国的医疗支出中，每4美元就有1美元用于已确诊的糖尿病。此外，还有数百万人患有其他慢性疾病，其中部分是由糖尿病引发的并发症。然而，在预约就诊之外，医疗系统持续、主动地接触患者的能力，仍受到临床医生短缺、行政负担以及传统医疗服务模式局限性的严重制约。

UpDoc is rewriting these rules..

UpDoc 正在重写这些规则。

'For too long, diabetes and other chronic disease management has been episodic while patients are left to navigate their conditions alone the rest of the time,' said Sharif Vakili, UpDoc's chief executive officer. 'UpDoc changes that equation entirely. This support from the American Diabetes Association isn't just a capital investment—it's a signal to the entire healthcare ecosystem that the future of chronic disease management is here and responsible clinical AI is a key part of delivering better care outcomes at scale.'.

“长期以来，糖尿病及其他慢性病的管理往往呈间断性，患者在其余时间里只能独自应对病情，”UpDoc首席执行官沙里夫·瓦基利表示，“UpDoc彻底改变了这一局面。来自美国糖尿病协会的支持不仅仅是一笔资本投资，更是向整个医疗生态系统发出的信号：慢性病管理的未来已经到来，而负责任的临床人工智能正是规模化实现更优诊疗效果的关键所在。”

The partnership between the ADA and UpDoc underscores a broader trend of leading health-focused organizations deploying venture capital as a tool for mission-aligned innovation. In addition to the ADA's strategic capital investment in UpDoc, the ADA provides deep clinical and research expertise, which will accelerate both product development and commercial adoption..

ADA与UpDoc的合作凸显了一个更广泛的趋势：领先的医疗健康机构正将风险投资作为推动与自身使命相契合的创新工具。除对UpDoc进行战略性资本投资外，ADA还将提供深厚的临床与科研专长，从而加速产品开发与商业化应用。

'UpDoc has built something genuinely innovative and has done so in a way that extends and amplifies, rather than replaces, the clinician-patient relationship,' said James Tai, ADA's board chair. 'Our investment reflects our commitment to bold, science-driven innovation that is properly regulated and built to scale, reaching millions of people who need better support today.'.

ADA董事会主席詹姆斯·泰表示：“UpDoc打造了真正具有创新性的成果，其方式延伸并强化了医患关系，而非取而代之。我们的投资彰显了我们对大胆且以科学为驱动的创新的支持，该创新在妥善监管下推进，具备规模化能力，能够惠及当今数百万需要更好支持的人群。”

About the American Diabetes Association

关于美国糖尿病协会

The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we're not stopping. There are 155 million Americans living with diabetes or prediabetes.

美国糖尿病协会（ADA）是美国领先的志愿健康组织，致力于为消除糖尿病而奋斗，并帮助人们享有健康生活。今年，ADA迎来了推动糖尿病预防、管理、治疗及最终治愈的发现与研究的第85周年——而我们的脚步不会停止。目前，美国有1.55亿人患有糖尿病或处于糖尿病前期。

Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at .

通过倡导、项目开发和教育，我们正为所有人争取权益。如需了解更多信息或参与其中，请访问我们的网站：。

diabetes.org

美国糖尿病协会官网

or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (

或拨打 1-800-DIABETES (800-342-2383)。在 Facebook 上加入我们共同抗击（

American Diabetes Association

美国糖尿病协会

), Spanish Facebook (

），西班牙语 Facebook（

Asociación Americana de la Diabetes

美国糖尿病协会

), LinkedIn (

), 领英 (

American Diabetes Association

美国糖尿病协会

), and Instagram (

），以及Instagram（

@AmDiabetesAssn

@美国糖尿病协会

). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (

）。如需进一步了解我们如何为所有受糖尿病影响的人群倡导权益，请访问我们的 X 平台（

@AmDiabetesAssn

@美国糖尿病协会

).

）。

About UpDoc

关于 UpDoc

UpDoc is an enterprise-ready clinical AI company pioneering a new care delivery paradigm that enables patients to receive continuous, physician-level care between scheduled visits. UpDoc's provider-integrated platform combines automated agentic AI with clinician oversight to safely manage chronic disease at scale, bringing proactive, high-touch care to every patient in a way that was never possible before..

UpDoc是一家具备企业级应用能力的临床AI公司，正开创一种全新的医疗服务交付范式，使患者能够在预约就诊的间隔期持续获得医生级别的医疗照护。UpDoc与医疗服务提供方深度集成的平台，将自动化智能体AI与临床医生的监督相结合，得以安全、规模化地管理慢性病，以以往从未实现的方式，为每位患者提供主动且高关怀度的医疗服务。

Media Contacts

媒体联系人

Virginia Cramer

弗吉尼亚·克拉默

[email protected]

[email protected]

(703) 253-4927

(703) 253-4927

Abbey Clark

阿比·克拉克

[email protected]

[电子邮件地址]

(631) 834-1070

(631) 834-1070

SOURCE American Diabetes Association

来源：美国糖尿病协会

21

二十一

%

百分号

more press release views with

通过……获得更多新闻稿浏览量

Request a Demo

申请演示